Fig. 5From: A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s diseaseDifferent levels of bias risk for each factor in the studies that were considered. The Cochrane risk of bias tool was used in order to determine publication biasBack to article page